Skip to main content
OpenTrials

Clinical trial condition

Alphavirus Infections

Explore clinical trials studying Alphavirus Infections. Study availability and eligibility vary by location and protocol.

77 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Alphavirus Infections trial results

Completed

Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

NCT04546724

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Accelerated Enrollment Solutions (AES) Chandler, Arizona, United States
  • Accelerated Enrollment Solutions (AES) Phoenix, Arizona, United States
  • Alliance for Multispecialty Research (AMR) Tempe, Arizona, United States
  • ELITE Research Network (ELITE) Little Rock, Arkansas, United States
View all 44 locations
View Trial Details
Completed

ZIKAlliance Pregnant Women Cohort

NCT03188731

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +13 more
Locations
  • Sosecali Ltd. (SOSE) Guaqui, Bolivia
  • INSERM Santa Cruz, Bolivia
  • Federal University of Bahia (UFB) Bahia, Brazil
  • Universidade Federal de Minas Gerais Belo Horizonte, Brazil
View all 14 locations
View Trial Details
Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine

NCT02861586

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +11 more
Locations
  • Hansa Sanatorium GmbH Graz, Austria
  • Medical University Vienna, Department of Clinical Pharmacology Vienna, Austria
  • Berliner Center for Travel- and Tropical Medicine Berlin, Germany
  • Medicinal University Rostock, Department for Tropical Medicin and infectious diseases Rostock, Germany
View Trial Details

Related conditions